Yosamin Gonzalez Belisario, Geert J L H van Leenders
{"title":"目前前列腺癌的分级。德国版)。","authors":"Yosamin Gonzalez Belisario, Geert J L H van Leenders","doi":"10.1007/s00292-025-01446-6","DOIUrl":null,"url":null,"abstract":"<p><p>The Gleason grading system is the cornerstone of risk stratification and clinical decision-making in prostate cancer patients. In the last decade, new insights on quantitative grading and the importance of particular growth patterns have further optimized pathological tumor grading. This review provides an update on the latest grading recommendations and discusses contemporary research directions.</p>","PeriodicalId":74402,"journal":{"name":"Pathologie (Heidelberg, Germany)","volume":" ","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Current grading of prostate cancer. German version].\",\"authors\":\"Yosamin Gonzalez Belisario, Geert J L H van Leenders\",\"doi\":\"10.1007/s00292-025-01446-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The Gleason grading system is the cornerstone of risk stratification and clinical decision-making in prostate cancer patients. In the last decade, new insights on quantitative grading and the importance of particular growth patterns have further optimized pathological tumor grading. This review provides an update on the latest grading recommendations and discusses contemporary research directions.</p>\",\"PeriodicalId\":74402,\"journal\":{\"name\":\"Pathologie (Heidelberg, Germany)\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2025-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pathologie (Heidelberg, Germany)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s00292-025-01446-6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathologie (Heidelberg, Germany)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00292-025-01446-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Current grading of prostate cancer. German version].
The Gleason grading system is the cornerstone of risk stratification and clinical decision-making in prostate cancer patients. In the last decade, new insights on quantitative grading and the importance of particular growth patterns have further optimized pathological tumor grading. This review provides an update on the latest grading recommendations and discusses contemporary research directions.